![These highlights do not include all the information needed to use ZILXI safely and effectively. See full prescribing information for ZILXI. ZILXI® (minocycline) topical foamInitial U.S. Approval: 1971 These highlights do not include all the information needed to use ZILXI safely and effectively. See full prescribing information for ZILXI. ZILXI® (minocycline) topical foamInitial U.S. Approval: 1971](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-11.jpg&id=656330)
These highlights do not include all the information needed to use ZILXI safely and effectively. See full prescribing information for ZILXI. ZILXI® (minocycline) topical foamInitial U.S. Approval: 1971
![VYNE Therapeutics' ZILXI Topical Minocycline Foam Now Available in Pharmacies Nationwide | MedEsthetics VYNE Therapeutics' ZILXI Topical Minocycline Foam Now Available in Pharmacies Nationwide | MedEsthetics](https://img.medestheticsmag.com/files/base/allured/all/image/2020/10/dreamstime_m_195978903.5f7c9f9f78b94.png?auto=format%2Ccompress&q=70&w=700)
VYNE Therapeutics' ZILXI Topical Minocycline Foam Now Available in Pharmacies Nationwide | MedEsthetics
![MENLO THERAPEUTICS: Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea | FDA Health News MENLO THERAPEUTICS: Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea | FDA Health News](https://s3.amazonaws.com/jnswire/jns-media/ae/2f/11433717/img_31052020_101854_-1000_x_667_pixel.jpg)
MENLO THERAPEUTICS: Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea | FDA Health News
![These highlights do not include all the information needed to use ZILXI safely and effectively. See full prescribing information for ZILXI. ZILXI® (minocycline) topical foamInitial U.S. Approval: 1971 These highlights do not include all the information needed to use ZILXI safely and effectively. See full prescribing information for ZILXI. ZILXI® (minocycline) topical foamInitial U.S. Approval: 1971](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-06.jpg&id=656330)
These highlights do not include all the information needed to use ZILXI safely and effectively. See full prescribing information for ZILXI. ZILXI® (minocycline) topical foamInitial U.S. Approval: 1971
![Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea](https://mma.prnewswire.com/media/1174565/Menlo_Therapeutics_Logo.jpg)